News
17h
HealthDay on MSNADHD Medications Remain Linked to Lower Risk for Real-World Adverse OutcomesAttention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
Many with ADHD grieve a life they feel they’ve missed. Healing begins by naming it—and choosing a new way forward.
A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...
Discover a study that explores how a personalised mHealth exercise program can effectively improve ADHD symptoms in children.
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
Is creativity really a strength of autism? A new study says not necessarily. When controlling for ADHD and cognitive ability, ...
A new study found that exposure to misinformation about ADHD on the platform reduced students’ factual knowledge but ...
Figures suggest adults with ADHD are five times more likely to try to take their own lives than those without it. | ITV News ...
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results